Answers are grounded in this paper and cite their sources.
Renewing the emphasis for minority participation in clinical trials is warranted. Policy changes are recommended.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: